Baker Bros. Advisors’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Baker Bros. Advisors’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-102,205	Closed	-$2.86M	–	115
2019 Q3	$2.86M	Buy	102,205 +2,800	+3%	+$45.4K	0.02%	80
2019 Q2	$1.4M	Buy	+99,405	New	+$945K	0.01%	91

Baker Bros. Advisors's DOVA Position: Q4 2019 in Review

Baker Bros. Advisors sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 102,205 shares — an estimated $2.86M sold.

Baker Bros. Advisors first reported a position in DOVA in Q2 2019 and held it in 2 quarters. The position peaked at $2.86M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Baker Bros. Advisors reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Baker Bros. Advisors sold 102,205 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $2.86M.
Baker Bros. Advisors first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
Baker Bros. Advisors's Dova Pharmaceuticals, Inc. Common Stock position peaked at $2.86M in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Baker Bros. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.